Privately-held Italian drugmaker Angelini Pharma has breached the Code of Practice for the Association of the British ...
US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...
Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...
US biotech major Biogen and privately-held Dayra Therapeutics have announced a research collaboration to discover and develop ...
Switzerland is becoming the benchmark for American drug prices, warns the trade body Interpharma. A new US model links ...
The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...
US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...
The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...
The US Food and Drug Administration (FDA) has approved Padcev (enfortumab vedotin-ejfv), a nectin-4 directed antibody-drug ...
Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...
Swiss biosimilars and generics company Sandoz today announced the European launch of Afqlir (aflibercept), a 2 mg vial kit ...
Australian drugmaker Mayne Pharma last week revealed it has been notified by USA-based Cosette Pharmaceuticals that it had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback